Sponsor or institution

Clinical trials and research at Teclison Ltd.

As of November 12, 2026, Find a Trial lists 3 clinical trials run by Teclison Ltd. that are recruiting, at sites in 2 countries (most in United States (3), Taiwan (1)). By phase: Phase 2 (2), Phase 1/2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.

Newest trials

StudyPhaseWhereStatusRegistered
Combining TATE and Pembrolizumab for advanced colorectal and lung cancer Phase 2 Orange, California and 2 other locations Recruiting Jan 8, 2021
Combining TATE and PD-1 Inhibitor for Liver Cancer Treatment Phase 2 Orange, California and 2 other locations Recruiting Aug 24, 2017
Combining tirapazamine with embolization for liver cancer treatment Phase 1/2 Palo Alto, California and 1 other locations Recruiting Jun 25, 2014

All recruiting trials (3)

Quick answers

How many clinical trials run by Teclison Ltd. are recruiting right now?

3, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 2 countries. The most sites are in United States (3 trials), Taiwan (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 2, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →

Last reviewed 2026-11-12 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.